Optimisation of Cardiac Resynchronisation Therapy by Non-invasive Cardiac Output - The CHOICE2 Study

University of Dundee31 enrolled

Overview

An evaluation of the role of resting and exercise cardiac output measurement, by the inert gas rebreathing method, in optimisation of patients with cardiac resynchronisation pacemakers.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

QUADRUPLE

Enrollment

Conditions

Heart Failure Cardiac Resynchronisation Pacemakers

Interventions

Optimisation of VV delayDEVICE

Programmed VV delay altered on device

Eligibility

Sex: ALLMin age: 18 YearsMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Cardiac Resynchronization Device in situ for Heart Failure Exclusion Criteria: * Unable to cope with mouthpiece * Estimated life expectancy \< 6 months

Locations (1)

University of Dundee

Dundee, United Kingdom

Outcomes

Primary Outcomes

6 minute hall walk test

Time frame: 4 months

Secondary Outcomes

Echocardiographic measures of desynchrony

Time frame: 3 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.